[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80362]], camposKey:1439-099X 2023-11-01 Brachytherapy in the prevention of recurrence of conjunctival melanoma: Results of a case report in a University Hospital in Valladolid, Spain10251030, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80363]], camposKey:1689-832X 2023-01-01 A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma350356, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80364]], camposKey:1699-048X 2023-01-01 Status of head and neck brachytherapy in Spain in 202200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58732]], camposKey:1689-832X 2021-01-01 Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical height117125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=57745]], camposKey:1699-048X 2020-01-01 Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration¿resistant prostate cancer. Results of The Uroncor Group (Uro¿Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)13781389, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59097]], camposKey:1689-832X 2019-01-01 Treatment planning considerations for 125I eye plaque brachytherapy280284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58741]], camposKey:0365-6691 2018-01-01 Intraocular metastasis: comparison of clinical presentation with a known and unknown primary tumour Metástasis intraoculares: comparación entre las formas de presentación clínica con tumor primario conocido y desconocido714, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15534]], camposKey:0365-6691 2018-01-01 Metástasis intraoculares: comparación entre las formas de presentación clínica con tumor primario conocido y desconocido714, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58738]], camposKey:1689-832X 2018-01-01 Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part I337346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58739]], camposKey:1689-832X 2018-01-01 Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part II347359, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58740]], camposKey:1689-832X 2018-01-01 Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses123131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58742]], camposKey:0002-9394 2017-08-01 Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit3945, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15532]], camposKey:0365-6691 2016-01-01 Linfoma folicular primario de la conjuntiva simulando conjuntivitis crónica8689, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53810]], camposKey:0365-6691 2016-01-01 Primary conjunctival follicular lymphoma mimicking chronic conjunctivitis Linfoma folicular primario de la conjuntiva simulando conjuntivitis crónica8689, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15529]], camposKey:0365-6691 2013-01-01 Tumor pigmentado del cuerpo ciliar: ¿benigno o maligno?485488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=27854]], camposKey:0004-0614 2012-01-01 Radioterapia externa de rescate en la recidiva bioquímica después de Prostatectomía Radical por cáncer de próstata.131144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43340]], camposKey:1134-248X 2004-01-01 Diseño, análisis y presentación de estudios: sembrar para luego recoger350, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43341]], camposKey:1134-248X 2004-01-01 Medida de la eficacia de las intervenciones clínicas1640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43339]], camposKey:1132-1989 2003-01-01 Segundas opiniones en oncología7990, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=27855]], camposKey:0378-4835 2003-01-01 Toxicidad por sobredosis de mitomicina5357][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][][]